Jennifer Prescott

Jennifer Prescott is a seasoned expert in epidemiology and molecular biology with extensive experience in the pharmaceutical and academic sectors. Currently a Principal Scientist in Epidemiology at Merck, Jennifer provides molecular epidemiology support for oncology products. Previously, as Director of Pharmacoepidemiology at Sanofi Genzyme, responsibilities included advising on epidemiological analyses and benefit-risk assessments. Jennifer's earlier roles included Senior Lead Scientist at Booz Allen Hamilton and various positions at prestigious institutions such as Brigham and Women's Hospital and Harvard Medical School, where key contributions included grant writing and database development for cancer studies. Jennifer holds a Ph.D. in Molecular Epidemiology from the University of Southern California and has participated in multiple workshops to enhance skills in causality and pharmacoepidemiology.